Table SI .

 SI Information for disease duration, onset age and body surface area of vitiligo patients. 


		Disease duration	Body surface
	Patient no.	(month)	area (%)
	1	32	15
	2	3	1
	3	12	12
	4	3	8
	5	6	15
	6	24	30
	7	33	45
	8	5	11
	9	8	12
	10	3	2
	11	43	80
	12	48	60
	13	35	75
	14	36	30
	15	7	20
	16	5	18
	17	4	2
	18	48	20
	19	12	16
	20	10	12

Table SII .

 SII Sequences of primers used for reverse transcriptionquantitative PCR. 


	Primer name	Sequence (5'-3')
	AhR FW	ACATCACCTACGCCAGTCGC
	AhR RV	TCTATGCCGCTTGGAAGGAT
	CYP1A1 FW	GAGGAGCTAGACACAGTGATTGG
	CYP1A1 RV	GAAGAGTGTCGGAAGGTCTCC
	CYP2E1 FW	AATGGACCTACCTGGAAGGAC
	CYP2E1 RV	CCTCTGGATCCGGCTCTCATT
	RORC FW	GCATGTCCCGAGATGCTGTC
	RORC RV	CTGGGAGCCCCAAGGTGTAG
	FoxP3 FW	ACCTGGAAGAACGCCATC
	FoxP3 RV	TGTTCGTCCATCCTCCTTTC
	IL17A FW	GTCAACCTGAACATCCATAACCG
	IL17A RV	ACTTTGCCTCCCAGATCACAG
	IL22 FW	CACTGCAGGCTTGACAAG
	IL22 RV	CTTAGCCTGTTGCTGAGC
	GAPDH FW	TCTGCTGATGCCCCCATGTTC
	GAPDH RV	GGATGATGTTCTGGAGAGCCC
	FW, forward; RV, reverse; AhR, aryl hydrocarbon receptor; CYP1A1,
	cytochrome P450 1A1; RORC, retinoic acid receptor-related orphan
	receptor C; FoxP3, forkhead box protein P3; IL, interleukin.